Andere Sprachen Waters Corporation London S.E.

Aktien

898123

US9418481035

0LTI

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:36:37 24.06.2024			% 5 Tage	% 1. Jan.
290,4 ^USD	-1,63 %		+0,71 %	-10,09 %

05.06.	Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
04.06.	ÖBAG verkauft Vamed-Beteiligung an Fresenius	DJ

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer	03.06.
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification	03.06.
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing	29.05.
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing	16.05.
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference	13.05.
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument	08.05.
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08.05.
Waters Seeks M&A Opportunities	07.05.
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued	07.05.
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M	07.05.
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21	07.05.
Waters: Q1 Earnings Snapshot	07.05.
Waters : Q1 2024 Non-GAAP	07.05.
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results	07.05.
Waters Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024	07.05.
Waters Corporation Provides Earnings Guidance for the Second Quarter Ending June 29, 2024 and Full Year Ending December 31, 2024	07.05.
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns	22.04.
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call	11.04.
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors	09.04.
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges	14.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Waters Corporation London S.E.

Aktien

898123

US9418481035

0LTI

Andere Sprachen

Filter